Enter your search term above.
Link back to homepage
Link back to homepage

News

According to preliminary findings from a small study presented Monday at the Society of Thoracic Surgeons’ annual meeting, a new drug ‘lights up’ stray lung cancer cells when looked through an imaging technique, reducing cancer recurrence post-surgery. In fact, the study found that the new combination—dubbed intraoperative molecular imaging (IMI)—helped improve outcomes in surgeries of 1 out of 4 patients.

Though not involved in the study, LCRF Board Chair Brendon M. Stiles, MD, recently shared his thoughts on the study with HealthDay. He told the media outlet that the potential for the new technology is “exciting” for certain types of early lung cancer lesions that aren’t easy to see or feel. “There really shouldn’t be any side effects; it’s fast and user-friendly,” said Dr. Stiles. But he added that the technology may be somewhat limited because near infrared light doesn’t see deeply into the body.” Pre-op imaging has gotten so amazingly good, we’re finding earlier and earlier cancers. It’s hard to think they’d find nodules that weren’t on the CT scan.” 

Click here to read the full article and learn more about the study.

Posted in Research
Catherine (center front) with some of the Clinical Trial Blazers team

Hundreds of participants—lung cancer patients, survivors, and advocates, young and old— took part in the 2019 New York Free to Breathe Walk last October. On event day, dozens of walkers were greeted with a hug from the same woman, Catherine Paykin, LCSW-R. Catherine, a social worker at NYU Perlmutter Cancer Center, was the common link between so many of the smiling faces at this year’s walk. She was team captain for NYU’s 2019 team, NYU Perlmutter Cancer Center Clinical Trial Blazers, recruiting a team of a whopping 175+ members over the course of just a few short months!

Catherine, like so many Free to Breathe team captains, is a go-getter. In a short amount of time, she raised over $50,000, 10 times her original fundraising goal!! And do you know what’s even more amazing? This was her first time as a team captain!

A group of Clinical Trial Blazers on walk day

So how did Catherine do it? In addition to inviting her patients, she recruited Audrey Sheridan, LCSW from the Brooklyn Perlmutter Cancer Center to rally forces in Kings County. Together they enlisted the help of eight NYU Perlmutter Cancer Center doctors, who in turn invited their patients to walk with them. And Catherine didn’t stop once people joined the team! She continually encouraged team members to set up their own personal fundraising goals and reach out to their family and friends for donations. She also provided updates to her team members on the top fundraisers and offered tips to help the team hit their next fundraising target.

Becoming a top fundraiser is much more doable than it might seem. Just keep Catherine’s words in mind: “Walking and raising money for research was a concrete way of letting my patients and families know that they are not alone. Our team of scientists, researchers, healthcare providers who joined the patients and families to walk across the Brooklyn Bridge gave all hope and encouragement.”

Posted in Fundraising

New York, NY (January 22, 2019) – The Lung Cancer Research Foundation® (LCRF), the largest lung cancer focused foundation in the US supporting lung cancer research, has unveiled its newly revamped website, lcrf.org.  The recently updated website has a fresh visual design, offers easy navigation and is mobile optimized.

LCRF is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. To date, LCRF has funded 370 research grants totaling nearly $34 million, the highest amount provided by an organization dedicated to funding lung cancer research.

The organization’s website rebuild was spearheaded by Speak Creative, a Tennessee-based digital agency. The site unifies LCRF’s quality content with the viewer, the lung cancer community, in mind. The homepage of the site contains three specific journeys— lung cancer patient/caregiver, lung cancer researcher and supporter/advocate—to help visitors navigate and easily obtain the information they are looking for.

“We are so proud and excited to debut our redesigned website,” said Dennis P. Chillemi, Executive Director, LCRF. “We hope that the new design will make for a more enjoyable user experience. Our goal is to make sure that visitors can easily find the information they are looking for, whether it’s information on the current research we are funding, the latest FDA approvals, or registration for an upcoming lung cancer community event.”

LCRF’s website will be updated regularly with new content including the latest lung cancer treatment advances, upcoming events and educational workshops, and updates on LCRF’s Scientific Grant Program and LCRF-funded investigators. Viewers can visit the new site and explore LCRF’s content by visiting www.lcrf.org.

# # #

About the Lung Cancer Research Foundation
The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. To date, LCRF has funded 370 research grants, totaling nearly $34 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. In addition to funding lung cancer research, the organization offers awareness and educational programs and brings the lung cancer community together through Free to Breathe Walks and other events nationwide. For more information, visit lc